Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

REGENXBIO Inc. (RGNX) Institutional Ownership & Insider Trading

165 institutions reported holding REGENXBIO Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 8 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RGNXREGENXBIO Inc.Follow RGNX — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
441.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

165 institutions held 64.2% of the shares. Across filers that reported both quarters, shares held changed -0.6%.

Increased+58New+21Decreased-51Closed-30

Largest moves, shares (millions)

Marshall Wace+1.3MCitadel Advisors+0.7MBlackRock+0.6MQube Research & Technologies-1.3MJPMorgan Chase-1.3MIntegral Health Asset…-0.7M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-1.4Sep 24-4.3Dec 24+0.4Mar 25+0.5Jun 25+3.5Sep 25-4.7Dec 25+1.6Mar 26-0.2Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2616542-0.6%58215130
Mar 2617843+4.2%55255723
Dec 2517341-10.3%59215611
Sep 2516345+8.4%55204814
Jun 2515942+1.1%59244624
Mar 2516442+0.9%48304842
Dec 2417742-9.3%55294938
Sep 2418644-3.8%60235121

REGENXBIO Inc. — questions

Who owns REGENXBIO Inc. stock?
165 institutions reported REGENXBIO Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (9.7%), Redmile Group, LLC (6.6%), STATE STREET CORP (4.5%).
Are REGENXBIO Inc. insiders buying or selling?
8 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from REGENXBIO Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.